Riggs Asset Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Riggs Asset Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,500	Closed	-$769	–	392
2022 Q4	$769	Buy	3,500 +1,325	+61%	+$396	﹤0.01%	300
2022 Q3	$1K	Buy	2,175 +1,175	+118%	+$802	﹤0.01%	321
2022 Q2	$1K	Buy	+1,000	New	+$664	﹤0.01%	295

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Riggs Asset Management's CEMI Position: Q1 2023 in Review

Riggs Asset Management sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 3,500 shares — an estimated $769 sold.

Riggs Asset Management first reported a position in CEMI in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

Riggs Asset Management reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
Riggs Asset Management sold 3,500 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $769.
Riggs Asset Management first reported a position in Chembio diagnostics, Inc. in Q2 2022 and held it in 3 quarters.
Riggs Asset Management's Chembio diagnostics, Inc. position peaked at $1K in Q3 2022.
30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Riggs Asset Management's 13F filing for Q1 2023, filed 9 May 2023.